Details of the Drug Therapeutic Target (DTT)

General Information of Drug Therapeutic Target (DTT) (ID: TTD2MLN)

DTT Name	Natural killer cell activation (NKA)
Gene Name	NKA
DTT Type	Successful target	[1]
UniProt ID	NOUNIPROTAC
TTD ID	T66030

Molecular Interaction Atlas (MIA) of This DTT

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This DTT

1 Approved Drug(s) Targeting This DTT

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Virulizin	DM0REZS	Breast cancer	2C60-2C65	Approved	[1]
------------------------------------------------------------------------------------

References

1	Virulizin, a novel immunotherapy agent, activates NK cells through induction of IL-12 expression in macrophages. Cancer Immunol Immunother. 2005 Nov;54(11):1115-26.